Wednesday 08 Jan, 2025 04:52 PM
Site map | Locate Us | Login
   Transformers & Rectifiers hits life high as Q3 PAT zooms to Rs 55 cr; board OKs 1:1 bonus issue    Prime Focus gains after arm incorporates new subsidiary    One 97 Communications Ltd leads losers in 'A' group    United Breweries drops after halting beer supply to TGBCL    Bharat Immunological & Biological Corporation Ltd leads losers in 'B' group    Suven Life spurts on initiating Phase-1 of clinical trial in US    Volumes jump at MMTC Ltd counter    Waaree Renewable Tech slips after CFO Dilip Panjwani resigns    Industrials stocks slide    Power shares slide    Consumer Durables shares fall    Visaka Industries spurts after Co's solar roofing product receives ALMM Certification    Aurobindo Pharma Ltd slips for fifth straight session    JSW Energy Ltd drops for fifth straight session    Hitachi Energy India Ltd drops for fifth straight session 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Caplin Point gains after receiving EIR report from USFDA for Tamil Nadu facility
07-Jan-25   14:45 Hrs IST

The inspection was conducted at Caplin Steriles' injectable and ophthalmic manufacturing unit in Gummidipoondi from 5 August 2024 to 9 August 2024. The inspection concluded with zero 483 observations, reflecting the company's commitment to maintaining the highest standards of quality and compliance.

The official announcement was made after market hours on 6th January 2025.

Caplin Point Laboratories is a fast-growing pharmaceutical company with a unique business model catering predominantly to emerging markets of Latin America and Africa. The company has manufacturing facilities that cater to a complete range of finished dosage forms.

The company's consolidated net profit grew 14.04% to Rs 130.80 crore on 17.81% increase in revenue from operations to Rs 483.10 crore in Q2 FY25 over Q2 FY24.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 38066081
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd